This excerpt taken from the GENZ 10-Q filed Nov 3, 2006.
RIGHTS TO PRODUCT
7.01 Ownership. Any and all improvements, discoveries and/or inventions, whether or not patentable, which may be made or conceived by CCC or any of the other CCC Affiliates manufacturing Product during the Initial Term or any Renewal Term of this Agreement and which is based on the Patent Rights, the Product or products using the Product, shall be the sole and exclusive property of Genzyme. CCC shall provide and shall cause any such CCC Affiliate to provide, full disclosure to Genzyme of all such improvements, discoveries, and/or inventions described above, and shall execute or cause to be executed any and all applications, assignments, or other instruments which Genzyme shall deem necessary or useful in order to apply for and obtain Letters Patent of the United States and all foreign countries for discoveries and improvements believed to be inventions, and shall assign and conveyor caused to be assigned and conveyed to Genzyme sole and exclusive right, title, and interest in and to the discoveries and improvements and to all patent applications and patents thereon. Genzyme will bear the cost of preparation of all such patent applications. Notwithstanding the above, Genzyme grants CCC a limited, perpetual, royalty-free, world-wide license for any improvements, inventions or discoveries (whether or not patentable) conceived by CCC during the Initial Term or any Renewal Term related to, or useful in connection with the Product manufacturing process (i) for CCCs use in the manufacture of the Product and (ii) for CCCs use in connection with the manufacture of another product that is not a polyallylamine-based pharmaceutical product and does not compete with the End Products.